Leading Innovations in Life Science: June 2024 Edition

Leading Innovations in Life Science: June 2024 Edition

Dear subscribers,

Welcome to our June 2024 edition! As a company dedicated to developing essential tools and technologies that foster innovation in the life sciences, MGI consistently invests in new technologies and optimized product solutions to meet diverse demands and challenging scenarios. This month, we are excited to share the latest updates to enhance your knowledge of MGI's capabilities.

Explore the key highlights from June:

  • Opening of European Headquarters in Berlin, Germany
  • New Records for high-altitude operation of two sequencers
  • Launch of AgriHigh Low-pass WGS Package
  • NGS Solutions in HIV-1 & Mycobacterium Tuberculosis Drug Resistance Sequencing
  • Feature Article from GenomeWeb discussing Biosecure Act impact


Opening of European Headquarters in Berlin, Germany

On June 4, MGI announced the opening of its new European headquarters in Berlin, Germany to support the life science community across the region.

Read the full press release to experience the grand opening in Berlin.


Leading Innovations in Life Science

Committed to building core tools and technologies that drive innovation in life science—this has been MGI's consistent pursuit since its inception. Over the past 8 years, we have continued to explore, uncover, and pioneer.

Experience our journey, expertise, and commitment in the latest corporate video.

  • Setting New Records for High-altitude Operation of Sequencers

Mount Everest, the highest mountain in the world, has always symbolized a threshold for human beings to push their physical limits. In the life science industry, Mount Everest also bears witness to boundless breakthroughs made by explorers.

MGI recently set a new record for sequencing applications by successfully conducting sample testing on its advanced DNBSEQ-E25 and DNBSEQ-G99 platforms at Mount Everest. Despite the extreme conditions, both sequencers demonstrated exceptional performance, delivering high-quality, reliable, and stable data.

Read the full press release to see how the sequencers performed at Mount Everest.

  • Introduction of AgriHigh Low-pass WGS package for Molecular Breeding

At PAGAsia 2024, MGI unveiled a cutting-edge solution for large-scale Low-pass Whole Genome Sequencing in agriculture, the revolutionary "AgriHigh Low-pass WGS package". Tailored for genotyping in molecular breeding of large-scale agricultural diploid species, it addresses user challenges with a seamless workflow of flexible automation, simplified library prep, high throughput sequencing, and streamlined data processing.

Read the full press release to have an overview of the product introduction.

  • Innovative Solutions in HIV-1 & Mycobacterium Tuberculosis Drug Resistance Sequencing

On June 7, MGI announced the launch of two MGI innovative solutions in Next Generation Sequencing (NGS) that will revolutionize our approach to infectious disease management and drug resistance analysis. These applications are designed to support healthcare professionals and researchers in their fight against infectious diseases by providing robust, reliable, and rapid results.


GenomeWeb: Biosecure Act Impacts Genomics Researchers Amidst Strained US-China Relations

In this featured article from GenomeWeb, the discussion revolves around how the proposed Biosecure Act may impede competition and innovation within the industry.

Researchers have expressed concerns about this potential impact. "We should protect intellectual property, but we also need to ensure competition and innovation in the market," wrote Christopher Mason, a genomics expert at Weill Cornell Medicine in an email.

Read the full article to learn more about the researchers' views and opinions.


Partnership with SeqOne Genomics to Advance End-to-end Genomic Analysis

On June 17th, MGI announced the collaboration with SeqOne, a leading provider of AI-driven genomic decision support software, to develop and validate end-to-end genomic analysis solutions from sample to report tailored to the needs of Human Genetics and Pathology labs worldwide.

Read the full press release for more details about the collaboration.

Don't Miss Out: Upcoming Events

  • STOC General Meeting 2024: July 8-10, Singapore

Visit us at Booth 8 at NTU to explore the forefront of multi-omics technology. We will also feature Dr. Wei-Yuan Yu delivering a keynote speech from 1 pm to 2:30 pm on July 8, introducing the groundbreaking applications and approaches from DCS Lab in the fields of single cells and related subjects. Don't miss it!

  • Medlab Asia 2024: July 10-12, Bangkok, Thailand

Visit us at Booth H7.E30 at Queen Sirikit National Convention Center to engage in idea exchanges and foster industrial collaborations.



Thank you for reading! Catch us next month and follow us on LinkedIn, X, and YouTube for more of the latest content from MGI. To get more information, please visit the MGI website.


Warmest regards,

The “MGI Newsletter” Editorial Team

要查看或添加评论,请登录

MGI的更多文章

社区洞察

其他会员也浏览了